Mode
Text Size
Log in / Sign up
N/A Completed N=15 Randomized Triple-blind Treatment

Functional Magnetic Resonance Imaging of Opioid Withdrawal in Healthy Human Volunteers

Source: ClinicalTrials.gov NCT01006707 ↗
Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Nov 2017
Primary outcomePrimary: Brain Regions With Increases or Decreases in Amplitude of Low Frequency Fluctuations (ALFF) Associated With Ondansetron Administration — 0.519; 0.562; 0.478; 0.486 correlation coefficient

Summary

Opioid medications are commonly used for pain relief. When given over time, physical dependence can occur. This results in unpleasant side effects--such as agitation and nausea--if opioid medications are suddenly stopped. However, we do not know how withdrawal affects the brain. We know that a medication named Ondansetron can help ease or prevent symptoms associated with opioid withdrawal. Through imaging of the brain by fMRI, we hope to see how opioid withdrawal, with and without the administration of ondansetron, affects brain activity.

Outcome Measures

OutcomeResultp-value
PRIMARY
Brain Regions With Increases or Decreases in Amplitude of Low Frequency Fluctuations (ALFF) Associated With Ondansetron Administration
0.519; 0.562; 0.478; 0.486; -0.612; 0.475
SECONDARY
Objective Opioid Withdrawal Scale Score 5 Minutes Following Ondansetron or Placebo Administration
1; 2 0.042 sig
SECONDARY
Objective Opioid Withdrawal Scale Score 15 Minutes Following Ondansetron or Placebo Administration
2.7; 2.2 0.322
SECONDARY
Subjective Opioid Withdrawal Scale (SOWS) Score 20 Minutes Following Ondansetron or Placebo Administration
5.7; 8.1 0.261

Eligibility Criteria

Inclusion Criteria

  • Patients will be healthy male volunteers, ages 18-35.

Exclusion Criteria

  • Females were excluded due to menstrual cycle modulation of opioid response.
  • We will exclude individuals with Raynaud's disease or a history of coronary artery disease.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01006707). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search